These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1632645)
1. The binding of estrogen and estrogen antagonists to the estrogen receptor. Bond JP; Sasson S; Notides AC Arch Biochem Biophys; 1992 Aug; 296(2):583-91. PubMed ID: 1632645 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen. Sasson S; Notides AC Mol Endocrinol; 1988 Apr; 2(4):307-12. PubMed ID: 3380103 [TBL] [Abstract][Full Text] [Related]
3. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA. Klinge CM; Traish AM; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617 [TBL] [Abstract][Full Text] [Related]
4. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands. Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Hanson MB; Gallion H; Flanigan RC; Kenady DE Biochemistry; 1985 Dec; 24(27):8101-6. PubMed ID: 4092059 [TBL] [Abstract][Full Text] [Related]
5. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen. Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064 [TBL] [Abstract][Full Text] [Related]
6. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies. Giambiagi N; Pasqualini JR J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244 [TBL] [Abstract][Full Text] [Related]
7. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7. Roos W; Oeze L; Löser R; Eppenberger U J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210 [TBL] [Abstract][Full Text] [Related]
8. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799 [TBL] [Abstract][Full Text] [Related]
9. High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. Furlow JD; Murdoch FE; Gorski J J Biol Chem; 1993 Jun; 268(17):12519-25. PubMed ID: 8509392 [TBL] [Abstract][Full Text] [Related]
10. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction. Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013 [TBL] [Abstract][Full Text] [Related]
11. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes. Tyulmenkov VV; Klinge CM Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829 [TBL] [Abstract][Full Text] [Related]
12. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines. Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835 [TBL] [Abstract][Full Text] [Related]
13. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology. Lewis DF; Parker MG; King RJ J Steroid Biochem Mol Biol; 1995 Jan; 52(1):55-65. PubMed ID: 7857874 [TBL] [Abstract][Full Text] [Related]
14. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351. MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635 [TBL] [Abstract][Full Text] [Related]
15. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
16. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA. Aliau S; Groblewski T; Borgna JL Eur J Biochem; 1995 Jul; 231(1):204-13. PubMed ID: 7628472 [TBL] [Abstract][Full Text] [Related]
17. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols. Aliau S; Mattras H; Richard E; Borgna JL Biochemistry; 1999 Nov; 38(45):14752-62. PubMed ID: 10555957 [TBL] [Abstract][Full Text] [Related]
18. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. Schwartz JA; Zhong L; Deighton-Collins S; Zhao C; Skafar DF J Biol Chem; 2002 Apr; 277(15):13202-9. PubMed ID: 11823467 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen. Attardi B; Happe HK Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150 [TBL] [Abstract][Full Text] [Related]
20. Characterisation of non-activated and activated estrogen- and antiestrogen-receptor complexes by high performance ion exchange chromatography. Myatt L; Wittliff JL J Steroid Biochem; 1986 May; 24(5):1041-8. PubMed ID: 3724142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]